Международная разработка

ClinicalTrials.gov

Исследования, вмешательства, заболевания, спонсоры, страны и результаты.

42 записей

Варианты написания учтены

салметерол → salmeterol проверенная транслитерация · 100% Основание: версионированный словарь · словарь 1.0.0 Поиск: salmeterol, салметерол, сальметерол, салметерола ксинафоат, salmeterol xinafoate, sal meterol
флутиказон → fluticasone проверенная транслитерация · 100% Основание: версионированный словарь · словарь 1.0.0 Поиск: fluticasone, флутиказон, flutikazon, флютиказон, флутиказона пропионат, fluticasone propionate

Результаты

ClinicalTrials.gov

факт источника аналитический сигнал

ClinicalTrials.gov для запроса салметерол, флутиказон
Исследование	Вмешательство / заболевание	Спонсор / страны	Фаза и статус	Сроки / участники	Результаты
Study Of Asthma In Patients Of African Descent NCT00102765 AACT · ClinicalTrials.gov Офлайн-снимок AACT · ClinicalTrials.gov	fluticasone fluticasone propionate powder salmeterol powder Asthma	GlaxoSmithKline United States	PHASE4 COMPLETED	30.11.2004 — 30.04.2007 479 участников	Не найдены Первоисточник ↗
Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate NCT00102882 AACT · ClinicalTrials.gov Офлайн-снимок AACT · ClinicalTrials.gov	fluticasone salmeterol Asthma	GlaxoSmithKline Kenya, Peru, Puerto Rico, United States	PHASE4 COMPLETED	31.10.2004 — 31.01.2007 547 участников	Не найдены Первоисточник ↗
Two Investigational Drugs in the Prevention of Airway Constriction Brought on by Exercise in Participants With Asthma (0476-911) NCT00127166 AACT · ClinicalTrials.gov Офлайн-снимок AACT · ClinicalTrials.gov	fluticasone montelukast sodium salmeterol Exercise Induced Asthma	Organon and Co Страны не указаны	PHASE3 COMPLETED	31.12.2005 — 30.11.2008 154 участников	Опубликованы Первоисточник ↗
The Leukotriene Modifier Or Corticosteroid or Corticosteroid-Salmeterol Trial NCT00156819 AACT · ClinicalTrials.gov Офлайн-снимок AACT · ClinicalTrials.gov	fluticasone montelukast fluticasone plus salmeterol Asthma	JHSPH Center for Clinical Trials United States	PHASE4 COMPLETED	30.06.2003 — 31.08.2006 500 участников	Опубликованы Первоисточник ↗
Pediatric Asthma Study Using Stepwise Treatment With Two Food And Drug Administration Approved Asthma Medications NCT00158834 AACT · ClinicalTrials.gov Офлайн-снимок AACT · ClinicalTrials.gov	fluticasone salmeterol fluticasone propionate combination product Asthma	GlaxoSmithKline Netherlands	PHASE3 COMPLETED	30.11.1999 — — 200 участников	Не найдены Первоисточник ↗
Study In Airway Physiology In Children SERETIDE DISKUS ® Inhlaer and FLIXOTIDE® Inhaler Are Trademarks of GSK Group of Companies. NCT00169546 AACT · ClinicalTrials.gov Офлайн-снимок AACT · ClinicalTrials.gov	fluticasone salmeterol Asthma	GlaxoSmithKline New Zealand, United Kingdom	PHASE4 COMPLETED	31.01.2003 — 31.12.2005 64 участников	Не найдены Первоисточник ↗
Treatment Of Symptomatic Asthma In Children NCT00197106 AACT · ClinicalTrials.gov Офлайн-снимок AACT · ClinicalTrials.gov	salmeterol 100 mcg fluticasone propionate 2 x 100 mcg fluticasone propionate diskus inhaler 50 +1 Asthma	GlaxoSmithKline Netherlands	PHASE4 COMPLETED	30.06.2005 — 31.10.2008 176 участников	Опубликованы Первоисточник ↗
Asthma Clinical Research Network (ACRN) Trial - Long-Acting Beta Agonist Response by Genotype (LARGE) NCT00200967 AACT · ClinicalTrials.gov Офлайн-снимок AACT · ClinicalTrials.gov	salmeterol beclomethasone hfa Asthma	Milton S. Hershey Medical Center United States	PHASE3 COMPLETED	31.12.2004 — 29.02.2008 87 участников	Опубликованы Первоисточник ↗
The Effect of Salmeterol on Eosinophil (EOS) Function NCT00214019 AACT · ClinicalTrials.gov Офлайн-снимок AACT · ClinicalTrials.gov	fluticasone salmeterol Allergic Asthma	University of Wisconsin, Madison United States	Фаза не указана COMPLETED	30.11.2003 — 31.01.2008 36 участников	Опубликованы Первоисточник ↗
Study to Assess the Incidence of Local Oropharyngeal and Laryngeal Adverse Effects of Advair DISKUS 250/50 mcg BID NCT00235053 AACT · ClinicalTrials.gov Офлайн-снимок AACT · ClinicalTrials.gov	fluticasone 50 salmeterol diskus 250 Asthma, Candidiasis, Oral, Voice Disorders	Allergy & Asthma Medical Group & Research Center United States	PHASE4 COMPLETED	31.08.2005 — 30.11.2005 13 участников	Не найдены Первоисточник ↗
Comparison of the Efficacy/Safety of Symbicort® Turbuhaler®,Seretide™ Diskus™ 50/500 µg & Terbutaline Turbuhaler® 0.4 mg NCT00242775 AACT · ClinicalTrials.gov Офлайн-снимок AACT · ClinicalTrials.gov	budesonide salmeterol fluticasone diskus formoterol turbuhaler +1 Asthma	AstraZeneca Argentina, Australia, Brazil, Canada, China, France, Germany, India, Indonesia, Malaysia, Mexico, Philippines, Singapore, South Africa, Spain, Thailand, Vietnam	PHASE3 COMPLETED	31.05.2005 — 31.05.2006 2 100 участников	Не найдены Первоисточник ↗
DESOLO - SiT Peri-Launch: A Comparison of Symbicort Single Inhaler Therapy and Conventional Best Practice for the Treatment of Persistent Asthma in Adults NCT00252863 AACT · ClinicalTrials.gov Офлайн-снимок AACT · ClinicalTrials.gov	budesonide fluticasone 4 5 g 50 g as needed prn budesonide turbuhaler 200 g fluticasone discus 250 g formoterol turbuhaler 160 formoterol turbuhaler 4 5 g salbutamol pressurized metered dose inhaler pmdi 100 g salmeterol discus 250 salmeterol discus 50 g salmeterol discus 500 singulair 10 mg symbicort terbutaline turbuhaler 0 5 mg theophylline 200 mg theophylline 300 mg used twice daily b i d +16 Asthma	AstraZeneca Germany	PHASE3 COMPLETED	31.12.2004 — 31.05.2006 1 600 участников	Не найдены Первоисточник ↗
Study In Asthma Control NCT00273026 AACT · ClinicalTrials.gov Офлайн-снимок AACT · ClinicalTrials.gov	fluticasone salmeterol Asthma	GlaxoSmithKline Canada	PHASE4 TERMINATED	08.11.2004 — 28.03.2006 680 участников	Не найдены Первоисточник ↗
Airway Hyper-responsiveness Study In Asthma Using Salmeterol/Fluticasone Propionate Combination Product NCT00291382 AACT · ClinicalTrials.gov Офлайн-снимок AACT · ClinicalTrials.gov	salmeterol fluticasone propionate combination Asthma	GlaxoSmithKline Belgium, Estonia, Finland, France, Germany, Italy, Latvia, Netherlands, Spain, Sweden	PHASE4 COMPLETED	30.11.2005 — 31.07.2007 150 участников	Не найдены Первоисточник ↗
Study Of Allergic Rhinitis In Patients Who Also Have Asthma NCT00296491 AACT · ClinicalTrials.gov Офлайн-снимок AACT · ClinicalTrials.gov	fluticasone advair diskus fluticasone propionate fp montelukast mon salmeterol fsc +2 Asthma	GlaxoSmithKline Canada, Estonia, Poland, United States	PHASE4 COMPLETED	30.09.2005 — 31.10.2007 725 участников	Опубликованы Первоисточник ↗
Study Of Patients With Allergic Rhinitis And Asthma NCT00296530 AACT · ClinicalTrials.gov Офлайн-снимок AACT · ClinicalTrials.gov	fluticasone montelukast salmeterol Asthma	GlaxoSmithKline United States	PHASE4 COMPLETED	30.09.2005 — 31.07.2007 600 участников	Не найдены Первоисточник ↗
Viapaed Study In Children And Adolescents With Asthma NCT00315744 AACT · ClinicalTrials.gov Офлайн-снимок AACT · ClinicalTrials.gov	fluticasone salbutamol salmeterol Asthma	GlaxoSmithKline Germany	PHASE4 COMPLETED	04.11.2004 — 12.04.2007 285 участников	Не найдены Первоисточник ↗
Pediatric ADVAIR DISKUS Versus Oral Montelukast Chewable Tablets NCT00328718 AACT · ClinicalTrials.gov Офлайн-снимок AACT · ClinicalTrials.gov	salmeterol 100mcg bid fluticasone propionate inhalation powder 50 montelukast 5mg qd +1 Asthma	GlaxoSmithKline Argentina, Colombia, Costa Rica, Mexico, Peru, Turkey (Türkiye), Venezuela	PHASE3 COMPLETED	31.10.2005 — 30.04.2007 526 участников	Не найдены Первоисточник ↗
Efficacy and Safety of Tiotropium and Salmeterol in Moderate Persistent Asthma Patients Homozygous for B16-Arg/Arg NCT00350207 AACT · ClinicalTrials.gov Офлайн-снимок AACT · ClinicalTrials.gov	salmeterol tiotropium bromide Asthma	Boehringer Ingelheim Austria, Belgium, Denmark, Finland, France, Germany, Greece, Italy, Russia, Slovakia, South Africa, Spain, Turkey (Türkiye), United Kingdom	PHASE2 COMPLETED	31.07.2006 — — 388 участников	Опубликованы Первоисточник ↗
A Comparative Study To Determine If Motivating Asthma Education (Compliance Enhancement) Has An Effect On Asthma Control NCT00351143 AACT · ClinicalTrials.gov Офлайн-снимок AACT · ClinicalTrials.gov	salmeterol 250 g 3 training sessions of compliance enhancement training fluticasone propionate 50 +1 Asthma	GlaxoSmithKline Denmark, Switzerland	PHASE4 COMPLETED	26.07.2005 — 13.06.2007 274 участников	Не найдены Первоисточник ↗
Seretide Versus Flixotide In Asthmatic Children Not Controlled By Inhaled Corticosteroids NCT00353873 AACT · ClinicalTrials.gov Офлайн-снимок AACT · ClinicalTrials.gov	fluticasone salmeterol Asthma	GlaxoSmithKline Belgium, Denmark, France, Italy, Latvia, Lithuania, Netherlands, Norway, Poland, Russia, Spain, Sweden	PHASE4 COMPLETED	18.11.2005 — 26.10.2006 506 участников	Опубликованы Первоисточник ↗
Results Of Patient Rated Asthma Control Test In Comparison To Diary Card Data NCT00363480 AACT · ClinicalTrials.gov Офлайн-снимок AACT · ClinicalTrials.gov	salmeterol 250 mcg fluticasone 50 salbutamol 100 mcg +1 Asthma	GlaxoSmithKline Germany	PHASE4 COMPLETED	17.05.2006 — 14.09.2007 221 участников	Опубликованы Первоисточник ↗
Repeat Dose Study of Fluticasone Propionate/Salmeterol Versus Fluticasone Propionate + Salmeterol In Asthmatics NCT00364442 AACT · ClinicalTrials.gov Офлайн-снимок AACT · ClinicalTrials.gov	fluticasone salmeterol Asthma	GlaxoSmithKline Germany	PHASE1 COMPLETED	28.01.2005 — 13.04.2005 12 участников	Не найдены Первоисточник ↗
Spacer Comparison In Adult Asthmatics NCT00369993 AACT · ClinicalTrials.gov Офлайн-снимок AACT · ClinicalTrials.gov	fluticasone salmeterol Asthma	GlaxoSmithKline New Zealand	PHASE2 COMPLETED	31.03.2005 — 31.05.2005 20 участников	Не найдены Первоисточник ↗
Study Of Airway Physiology In Adults. SERETIDE DISKUS® Inhaler and FLIXOTIDE® Inhaler Are Trademarks of GSK Croup of Companies. NCT00370591 AACT · ClinicalTrials.gov Офлайн-снимок AACT · ClinicalTrials.gov	fluticasone salmeterol Asthma	GlaxoSmithKline United Kingdom	PHASE4 COMPLETED	31.12.2002 — 30.04.2004 48 участников	Не найдены Первоисточник ↗
Study of Mometasone Furoate/Formoterol Combination and Fluticasone/Salmeterol in Persistent Asthmatics Previously Treated With Inhaled Glucocorticosteroids (P04139) NCT00379288 AACT · ClinicalTrials.gov Офлайн-снимок AACT · ClinicalTrials.gov	fluticasone 10 mcg bid 50 mcg bid mometasone furoate combination mdi 200 mometasone furoate combination mdi 400 salmeterol 250 salmeterol 500 +4 Asthma	Organon and Co Страны не указаны	PHASE3 COMPLETED	30.06.2006 — 30.11.2007 404 участников	Опубликованы Первоисточник ↗
Childhood Asthma Research and Education (CARE) Network Trial - Best Add-On Therapy Giving Effective Response (BADGER) NCT00395304 AACT · ClinicalTrials.gov Офлайн-снимок AACT · ClinicalTrials.gov	fluticasone montelukast salmeterol Asthma	Milton S. Hershey Medical Center United States	PHASE3 COMPLETED	31.03.2007 — 31.12.2011 182 участников	Опубликованы Первоисточник ↗
Dose Ranging Study for Indacaterol in Japanese Asthma Patients NCT00403754 AACT · ClinicalTrials.gov Офлайн-снимок AACT · ClinicalTrials.gov	indacaterol salmeterol Asthma	Novartis Pharmaceuticals Japan	PHASE2 COMPLETED	30.11.2006 — 30.11.2007 41 участников	Опубликованы Первоисточник ↗
Evaluation Of Patient Satisfaction Of Metered Dose Inhaler (MDI) With Counter In Asthmatics And Chronic Obstructive Pulmonary Disease Patients (COPD). NCT00404261 AACT · ClinicalTrials.gov Офлайн-снимок AACT · ClinicalTrials.gov	fluticasone salmeterol hfa Asthma	GlaxoSmithKline Australia	PHASE4 COMPLETED	31.01.2007 — 31.08.2007 132 участников	Не найдены Первоисточник ↗
Study of Inhaled Glucocorticosteroids/Long-Acting Bronchodilator Drugs in Subjects With Asthma That Have Been Taking Inhaled Glucocorticosteroids (Study P04705AM1) NCT00424008 AACT · ClinicalTrials.gov Офлайн-снимок AACT · ClinicalTrials.gov	fluticasone mometasone furoate f mdi formoterol mf salmeterol f sc dpi +3 Asthma	Organon and Co Страны не указаны	PHASE3 COMPLETED	30.04.2007 — 30.11.2008 722 участников	Опубликованы Первоисточник ↗
A 12-Week Study To Assess The Safety Of Fluticasone Propionate/Salmeterol 100/50 Hydrofluoroalkane (HFA) Versus Fluticasone Propionate 100 HFA In Children With Asthma NCT00441441 AACT · ClinicalTrials.gov Офлайн-снимок AACT · ClinicalTrials.gov	fluticasone salmeterol Asthma	GlaxoSmithKline Australia, Canada, Chile, Costa Rica, Germany, Latvia, Lithuania, Mexico, Peru, Poland, Russia, Spain, United States	PHASE3 COMPLETED	28.02.2007 — 31.01.2008 351 участников	Опубликованы Первоисточник ↗
Clinical Assessment Of GW815SF HFA MDI In Pediatric Patients With Bronchial Asthma NCT00448435 AACT · ClinicalTrials.gov Офлайн-снимок AACT · ClinicalTrials.gov	fluticasone salmeterol gw815sf hfa mdi Bronchial Asthma	GlaxoSmithKline Japan	PHASE3 COMPLETED	30.04.2007 — 31.01.2008 51 участников	Опубликованы Первоисточник ↗
A 12-Month Study Comparing Fluticasone Propionate/Salmeterol (ADVAIR) DISKUS Combination Product 250/50mcg Twice Daily To Fluticasone Propionate (FLOVENT) DISKUS 250 mcg Twice Daily In Symptomatic Patients With Asthma NCT00452348 AACT · ClinicalTrials.gov Офлайн-снимок AACT · ClinicalTrials.gov	fluticasone 50 mcg bid fluticasone propionate 250 mcg bid salmeterol xinofoate 250 +1 Asthma	GlaxoSmithKline Argentina, Brazil, Canada, Philippines, United States	PHASE4 COMPLETED	31.05.2007 — 30.04.2009 628 участников	Опубликованы Первоисточник ↗
A 12-Month Study Comparing Fluticasone Propionate/Salmeterol (ADVAIR) DISKUS Combination Product 250/50mcg BID To Fluticasone Propionate (FLOVENT) DISKUS 250 mcg BID In Symptomatic Subjects With Asthma NCT00452699 AACT · ClinicalTrials.gov Офлайн-снимок AACT · ClinicalTrials.gov	fluticasone 50 mcg bid fluticasone propionate 250 mcg bid salmeterol xinofoate 250 +1 Asthma	GlaxoSmithKline Argentina, Brazil, Canada, Philippines, United States	PHASE4 COMPLETED	31.05.2007 — 31.05.2009 621 участников	Опубликованы Первоисточник ↗
SERETIDE 100/50 bd (Twice Daily) Versus FLIXOTIDE 100 bd As Initial Maintenance Therapy In Moderate Asthma In Adults NCT00461500 AACT · ClinicalTrials.gov Офлайн-снимок AACT · ClinicalTrials.gov	fluticasone salmeterol fluticasone propionate combination Asthma	GlaxoSmithKline Страны не указаны	PHASE4 COMPLETED	31.03.2007 — 31.12.2007 81 участников	Опубликованы Первоисточник ↗
A Blinded Study To Examine The Ability Of PF-610,355 To Open The Airways In Asthmatic Patients. NCT00468975 AACT · ClinicalTrials.gov Офлайн-снимок AACT · ClinicalTrials.gov	investigational:pf 610 salmeterol 355 Asthma	Pfizer Germany, Sweden, United Kingdom	PHASE2 COMPLETED	31.05.2007 — — 42 участников	Не найдены Первоисточник ↗
Childhood Asthma Research and Education (CARE) Network Trial - Montelukast or Azithromycin for Reduction of Inhaled Corticosteroids in Childhood Asthma (MARS) NCT00471809 AACT · ClinicalTrials.gov Офлайн-снимок AACT · ClinicalTrials.gov	azithromycin budesonide montelukast salmeterol +1 Asthma	National Heart, Lung, and Blood Institute (NHLBI) United States	PHASE4 TERMINATED	31.03.2006 — 31.03.2007 210 участников	Не найдены Первоисточник ↗
CONCEPT: A 1-Year Comparison Of A Stable Dose Of SERETIDE® Inhaler With An Adjustable Maintenance Dose Of SYMBICORT® Inhaler. SERETIDE® Inhaler is a Trademark of GSK Group of Companies. SYMBICORT® Inhaler is a Trademark of Astra Zeneca. NCT00479739 AACT · ClinicalTrials.gov Офлайн-снимок AACT · ClinicalTrials.gov	budesonide salmeterol fluticasone propionate or formoterol Asthma	GlaxoSmithKline Australia, Austria, Belgium, Bulgaria, Canada, Estonia, Finland, Germany, Ireland, Latvia, Netherlands, New Zealand, North Macedonia, Spain, United Kingdom	PHASE4 COMPLETED	30.11.2002 — 31.07.2004 700 участников	Не найдены Первоисточник ↗
Successful Control and Clinical Effectiveness Of SERETIDE(Salmeterol/Fluticasone Propionate) Study In Asthma.(SUCCESS) NCT00480649 AACT · ClinicalTrials.gov Офлайн-снимок AACT · ClinicalTrials.gov	fluticasone salmeterol Asthma	GlaxoSmithKline South Korea	PHASE4 COMPLETED	31.01.2004 — 30.09.2005 424 участников	Не найдены Первоисточник ↗
Study Of RV-39 In Patients Who Also Have Asthma NCT00503009 AACT · ClinicalTrials.gov Офлайн-снимок AACT · ClinicalTrials.gov	fluticasone salmeterol Asthma	GlaxoSmithKline United States	PHASE4 TERMINATED	31.10.2007 — 31.07.2008 16 участников	Опубликованы Первоисточник ↗
Bronchodilatory Efficacy of a Single Dose QMF149 (Indacaterol Maleate/Mometasone Furoate) Via the Twisthaler® Device in Adult Patients With Asthma NCT00556673 AACT · ClinicalTrials.gov Офлайн-снимок AACT · ClinicalTrials.gov	indacaterol maleate mometasone furoate salmeterol fluticasone proprionate +1 Asthma	Novartis France, Germany	PHASE2 COMPLETED	31.10.2007 — 30.04.2008 31 участников	Опубликованы Первоисточник ↗
Examining the Link Between Obesity, Inflammation, and Response to Asthma Medications NCT00557180 AACT · ClinicalTrials.gov Офлайн-снимок AACT · ClinicalTrials.gov	salmeterol tiotropium bromide beclomethasone dipropionate hfa Asthma, Obesity	National Jewish Health United States	Фаза не указана COMPLETED	31.10.2007 — 28.02.2011 33 участников	Не найдены Первоисточник ↗

салметерол, флутиказон

ClinicalTrials.gov